معرفی
Richard Lifton is an Adjunct Professor of Genetics at Yale School of Medicine, where he previously served as Chair of the Department of Genetics (1998–2016). He holds a Sterling Professorship and is an Investigator at the Howard Hughes Medical Institute. His research focuses on using human genetics and genomics to identify genetic mutations underlying diseases like hypertension, cardiovascular disorders, and renal diseases. He pioneered exome sequencing, revolutionizing clinical diagnostics.
Education: BA from Dartmouth College (1975), MD and PhD in Biochemistry from Stanford University (1982, 1986). Clinical training in Internal Medicine at Brigham and Women’s Hospital. Leadership roles include membership in the National Academy of Sciences and Breakthrough Prize in Life Sciences (2014).
Research interests include hypertension mechanisms, renal salt reabsorption, and genetic causes of congenital heart diseases. His work on exome sequencing enabled discovery of genes linked to cardiovascular, renal, and neoplastic diseases. Key contributions include identifying pathways regulating blood pressure and electrolyte homeostasis.
Awards: Breakthrough Prize in Life Sciences, Wiley Prize, and numerous honors from medical societies. Active in academic governance, serving on councils of the National Academy of Sciences and NIH. His lab collaborates globally, advancing precision medicine initiatives.
Grants and advising: Extensive funding from NIH and private foundations. Advised on the President’s Precision Medicine Initiative. Mentor to researchers in genetics and genomics.
Labs/Teams: Yale Center for Genome Analysis, collaborations with Broad Institute and Whitehead Institute. Research teams focus on rare genetic variants and their impact on common diseases.
